• No results found

[PDF] Top 20 Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

Has 10000 "Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy" found on our website. Below are the top 20 most common "Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy".

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

... for central subfield mean thickness were recorded as central macular ...thickness. Central macular thickness and macular volume measure- ments at each time ... See full document

8

Alternative treatment methods in eyes with pseudophakic cystoid macular edema

Alternative treatment methods in eyes with pseudophakic cystoid macular edema

... icant reduction in CMT after Intravitreal ...2 patients with persistent IGS who had nearly immediate improvement of visual acuity 4 to 5 lines and a complete resolution of ME after a ... See full document

7

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

... and reduction in macular thickness in eyes with ...centers. Patients were included in the THUNDER- BIRD study if they had focal or diffuse DME involving the central fovea with a CMT of ... See full document

6

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema

... 66 patients had CRT ,400 µ m (group 1) and 94 eyes of 76 patients had CRT ...few patients required intravitreal triamci- nolone during the study period, more patients in group 2 ... See full document

6

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

... in patients with documented DME which, in the opinion of the treating physician, would benefit from anti-VEGF ...of central macular thickness nor specific standardized retreatment criteria ... See full document

7

Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion

Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion

... (eg, letters gained and VA improvement) as therapeutic effects without consideration of anatomical outcomes and AEs. Therefore, the current systematic review and network meta-analysis was performed to overcome the ... See full document

15

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology

... of macular thickness within the 10° and 20° fields of the occluded region between the SRD (−) group and the SRD (+) group, while there were no significant differences between the two groups with regard to ... See full document

10

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion

... Both patients received IVTA under local anesthesia. For intravitreal therapy, ...Both patients were followed up for at least 6 months postoperatively. Macular sensitivity was ... See full document

6

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

... weeks after initial injection, a similar evalua- tion was ...initial edema as defined by CMT , 300 µ m, at 2 weeks and 6 weeks after intravitreal injection of either ranibizumab or ... See full document

7

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion

... of intravitreal dexamethasone implant (Ozurdex) on macular morphology and functions in eyes with macular edema (ME) second- ary to retinal vein ...and central retinal thickness ... See full document

7

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema

... month after treatment by measuring the BCVA 1 day after IVR ...h after IVB injection signifi- cantly decreased compared with baseline and that a reduction in the FT 1 h after IVB was ... See full document

6

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOW

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW

... diffuse macular edema after IVT ...outcomes after 18 weeks of treatment was preceded by a posterior sub-Tenon's capsule injection of ...and macular thickness outcomes had no ... See full document

9

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

... 19 patients diagnosed with macular edema secondary to ...recruited after ethical clearance was obtained from The Ethical Committee of Padjadjaran ...were patients (less than 3 months of ... See full document

6

Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery

Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery

... years after the operation), the corrected distance visual acuity (CDVA) was 20/125 and the CME was detectable at biomicroscopy, optical coherence tomography (OCT; Stratus OCT©, Carl Zeiss Meditec, Dublin, CA, ... See full document

6

Retinal vein occlusion: pathophysiology and treatment options

Retinal vein occlusion: pathophysiology and treatment options

... related macular degeneration (n-AMD), is a monoclonal antibody fragment derived from the same parent murine antibody as bevaci- ...of macular edema in RVO, were presented at the Retina Congress ... See full document

8

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion

... retinal thickness was defined as the distance between the inner surface and the outer surface of ...retina. Patients were divided into two groups according to spectral domain OCT findings of SRD and CME: ... See full document

6

The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey

The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey

... male patients can indicate a higher prevalence of ...the patients with DME ...the patients without DME ...of macular edema at the 9-year follow-up, and halved the ap- plication of focal ... See full document

8

Treatments for macular oedema following central retinal vein occlusion : systematic review

Treatments for macular oedema following central retinal vein occlusion : systematic review

... Some anti-VEGF therapies, including bevacizumab, ranibizumab and a fl ibercept, have also been shown to be effective in short-term studies for the treatment of patients with macular oedema and CRVO. ... See full document

13

Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study

Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study

... twenty patients with macular edema secondary to chronic non-ischemic CRVOs were switched to intravitreal aflibercept injection (IAI) ...cularization. Patients must have received ... See full document

7

Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification

Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification

... of macular edema after vitrectomy than after phacoemulsification and intraocu- lar lens ...placement. Macular edema as a consequence of vitrectomy has probably been ... See full document

7

Show all 10000 documents...